VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance

(University of Texas M. D. Anderson Cancer Center) Researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers.